New testing platform for cardiac safety of medications
Dr. Lika Drakhlis and Prof. Dr. Robert Zweigerdt aim to integrate 3D organoids into a multilayer electrode network to better predict the cardiac safety of medications.
EIC Transition
More impact against cancer
Natural killer cells (NK cells) are part of the first line of defense of our immune system. They eliminate virus-infested cells and tumor cells. This makes NK cells interesting helpers in cancer therapy. Professor Dr. Dr. Axel Schambach, head of the Institute of Experimental Haematology at the Hannover Medical School (MHH), wants to genetically modify the immune cells in such a way that they detect and destroy the tumor cells even more reliably.
FIBREX: On the home stretch to the RNA drug against cardiac fibrosis
About four million people in Germany suffer from cardiac insufficiency. One characteristic of the disease is the stiffening of the heart muscle because connective tissue cells are deposited, the so-called fibrosis.